Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Clinical Science and Epidemiology

Whole-Genome Analysis of Clinical Vibrio cholerae O1 in Kolkata, India, and Dhaka, Bangladesh, Reveals Two Lineages of Circulating Strains, Indicating Variation in Genomic Attributes

Daichi Morita, Masatomo Morita, Munirul Alam, Asish K. Mukhopadhyay, Fatema-tuz Johura, Marzia Sultana, Shirajum Monira, Niyaz Ahmed, Goutam Chowdhury, Shanta Dutta, Thandavarayan Ramamurthy, Prosenjit Samanta, Eizo Takahashi, Keinosuke Okamoto, Hidemasa Izumiya, Makoto Ohnishi
Frederick M. Ausubel, Editor
Daichi Morita
aCollaborative Research Center of Okayama University for Infectious Diseases in India, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masatomo Morita
bDepartment of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Munirul Alam
cicddr,b - International Center for Diarrheal Diseases Research, Bangladesh, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asish K. Mukhopadhyay
dICMR—National Institute of Cholera and Enteric Diseases, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatema-tuz Johura
cicddr,b - International Center for Diarrheal Diseases Research, Bangladesh, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marzia Sultana
cicddr,b - International Center for Diarrheal Diseases Research, Bangladesh, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shirajum Monira
cicddr,b - International Center for Diarrheal Diseases Research, Bangladesh, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niyaz Ahmed
cicddr,b - International Center for Diarrheal Diseases Research, Bangladesh, Dhaka, Bangladesh
eDepartment of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Goutam Chowdhury
dICMR—National Institute of Cholera and Enteric Diseases, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shanta Dutta
dICMR—National Institute of Cholera and Enteric Diseases, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thandavarayan Ramamurthy
dICMR—National Institute of Cholera and Enteric Diseases, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prosenjit Samanta
dICMR—National Institute of Cholera and Enteric Diseases, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eizo Takahashi
aCollaborative Research Center of Okayama University for Infectious Diseases in India, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keinosuke Okamoto
aCollaborative Research Center of Okayama University for Infectious Diseases in India, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hidemasa Izumiya
bDepartment of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hidemasa Izumiya
Makoto Ohnishi
bDepartment of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick M. Ausubel
Mass General Hospital
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.01227-20
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Vibrio cholerae serogroup O1 is responsible for epidemic and pandemic cholera and remains a global public health threat. This organism has been well established as a resident flora of the aquatic environment that alters its phenotypic and genotypic attributes for better adaptation to the environment. To reveal the diversity of clinical isolates of V. cholerae O1 in the Bay of Bengal, we performed whole-genome sequencing of isolates from Kolkata, India, and Dhaka, Bangladesh, collected between 2009 and 2016. Comparison with global isolates by phylogenetic analysis placed the current isolates in two Asian lineages, with lineages 1 and 2 predominant in Dhaka and Kolkata, respectively. Each lineage possessed different genetic traits in the cholera toxin B subunit gene, Vibrio seventh pandemic island II, integrative and conjugative element, and antibiotic-resistant genes. Thus, although recent global transmission of V. cholerae O1 from South Asia has been attributed only to isolates of lineage 2, another distinct lineage exists in Bengal.

IMPORTANCE Cholera continues to be a global concern, as large epidemics have occurred recently in Haiti, Yemen, and countries of sub-Saharan Africa. A single lineage of Vibrio cholerae O1 has been considered to be introduced into these regions from South Asia and to cause the spread of cholera. Using genomic epidemiology, we showed that two distinct lineages exist in Bengal, one of which is linked to the global lineage. The other lineage was found only in Iran, Iraq, and countries in Asia and differed from the global lineage regarding cholera toxin variant and drug resistance profile. Therefore, the potential transmission of this lineage to other regions would likely cause worldwide cholera spread and may result in this lineage replacing the current global lineage.

INTRODUCTION

Cholera, which constitutes a disease of acute severe diarrhea, remains a major public health problem in developing countries. Historically, cholera pandemics have been recorded seven times since 1817, with the seventh cholera pandemic still ongoing since 1961 (1). Recently, serious country-wide cholera epidemics have been reported in both Haiti and Yemen (2, 3). In Haiti, no cholera had been reported until after the earthquake in 2010, at which time cholera spread across the country and became endemic. Nearly 800,000 Haitians have been afflicted by cholera, and over 9,000 have died (4). In comparison, the cholera outbreak in Yemen began in October 2016, resulting in Yemen being the first country on record to report more than one million suspected cases in a single year (5).

Vibrio cholerae comprises over 200 serogroups based on their somatic O antigens, among which serogroup O1 and O139 strains cause epidemic cholera (6). The O1 serogroup is divided into two biotypes, classical and El Tor. Notably, the first six pandemics appear to have been caused by the O1 classical biotype, whereas the El Tor biotype constitutes the causative agent in the seventh pandemic. Moreover, although previously cholera was caused only by biotype O1, in 1992 a new serogroup of V. cholerae, O139, was identified as the cause of epidemic cholera in India and Bangladesh (7).

In addition, several variants of the El Tor biotype have emerged and replaced the typical El Tor (8–12). Representative single nucleotide variations (SNVs) in such variants are found in genes for the cholera toxin B subunit (ctxB), major subunit of toxin-coregulated pilus (tcpA), multifunctional, autoprocessing repeats-in-toxin toxin (rtxA), and carR, which encodes the response regulator involved in the resistance phenotype against polymyxin B. For example, early in the seventh pandemic, the typical El Tor isolate possessed ctxB3, following which an El Tor variant harboring ctxB1 emerged and disseminated. More recently, isolates possessing ctxB7 were detected in the Haiti and Yemen outbreaks. Along with the shift of the ctxB genotype from ctxB3 to ctxB1, V. cholerae O1 El Tor acquired the integrative and conjugative element (ICE) of the SXT/R391 family via horizontal transfer. ICE contains several antibiotic resistance genes, including those for sulfamethoxazole and trimethoprim (together often abbreviated as SXT), which had previously been used in the treatment of cholera. Therefore, the current V. cholerae O1 generally exhibits multidrug resistance. There are four pathogenicity islands in the epidemic V. cholerae O1 genome, which are Vibrio pathogenicity island 1 (VPI-1), VPI-2, Vibrio seventh pandemic island I (VSP-I), and VSP-II. It has also been reported that VSP-II had genetic heterogeneity in El Tor strains, and their characteristics were highly related to the ctxB genotype (13–17).

Recently, whole-genome sequencing analysis of V. cholerae strains has provided fresh insight regarding the sites of strain emergence and worldwide spread. Several recent articles based on whole-genome sequencing have depicted South Asia as serving as a cradle of all epidemic and pandemic strains that lead to waves of cholera outbreaks worldwide (9, 12, 18, 19). In particular, the Bay of Bengal area in South Asia is known as a zone for cholera endemicity, and it is considered that this region constitutes a hot spot for the emerging epidemic strains. Thus, changes in epidemic V. cholerae O1 in the Bay of Bengal area may influence the globally prevalent V. cholerae. To understand the phylogeny of V. cholerae O1 in Bengal, we performed whole-genome sequencing of 125 clinical V. cholerae O1 isolates in Kolkata, India, and Dhaka, Bangladesh, collected from 2009 to 2016. The isolates were divided into two lineages by phylogenetic analysis and exhibited different genetic traits of ctxB, ICE, and VSP-II in accordance with each lineage. The population structure of the dominant lineage differed between Kolkata and Dhaka, although isolates from both lineages were detected in each region. Therefore, two distinct lineages which likely constitute candidates for generating new cholera pandemics exist in Bengal and represent a global threat for not only international but also intercontinental transmission.

RESULTS

Phylogenetics and phylodynamics of V. cholerae O1 in Kolkata and Dhaka.We placed the 125 isolated strains from Kolkata and Dhaka among a global collection of 1,178 V. cholerae isolates by phylogenetic analysis based on the core genome single nucleotide variations (SNVs) (see Tables S1 and S2 in the supplemental material). All strains except M66-2 as an outgroup belonged to the seventh pandemic El Tor clade (Fig. 1A), with recent South Asian strains being classified into two lineages, Asian lineage 1 and Asian lineage 2. Asian lineage 1 also contained isolates from Iran, Iraq, China, and Vietnam, and isolates in Asian lineage 2 were introduced into Africa, Haiti, and Yemen by different events. All the Bengali isolates in this study belonged to the wave 3 clade of the seventh pandemic El Tor and were located on Asian lineage 1 or 2. Comparison of the dominant lineages in each year revealed a different temporal shift between Kolkata and Dhaka (Fig. S1). In Kolkata, the proportions of the two lineages initially appeared to be substantially equal, whereas after 2010 almost all isolates belonged to lineage 2. In comparison, in Dhaka, the dominance of lineage 1 fluctuated, decreasing once each in 2010 and 2011 and then being restored. Therefore, we performed phylodynamic analysis of the isolates from Kolkata and Dhaka to trace the sequential genomic changes and elucidate the detailed population structure of V. cholerae O1.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Phylogenetic and phylodynamic analysis of V. cholerae O1. (A) Maximum-likelihood phylogeny was determined using core genome alignment. Overall, 7,451 SNVs were identified in 1,303 strains; M66-2 was used as the outgroup. Branch color indicates the geographical region of origin for each strain: Asia, blue; Latin America, yellow; Africa, red; Europe, cyan; Middle East, green; unknown, gray. Colored boxes on the outside tree indicate strains from Dhaka, Bangladesh (dark green), and Kolkata, India (saffron yellow). Asian lineages are indicated with an outside gray curve. (B) Maximum clade credibility tree of 59 strains from Dhaka, Bangladesh, and 66 strains from Kolkata, India. Colored bars show information regarding the country (Bangladesh, dark green; India, saffron yellow), ctxB type (ctxB1, red; ctxB7, blue; negative, gray), and carR type (wild-type carR, violet; carR G265A, cyan). (C) Effective population size of V. cholerae O1 in the Bengal region, June 2005 to December 2016. The blue line represents the median effective population size estimate, and the shaded area represents the 95% high posterior density (95% HPD) interval.

TABLE S1

Characterization of V. cholerae O1 isolates in Bengal. Download Table S1, XLSX file, 0.02 MB.
Copyright © 2020 Morita et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S2

List of genomes from public databases. Download Table S2, XLSX file, 0.03 MB.
Copyright © 2020 Morita et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S1

Fate of the dominant lineage in each region. The proportion of each lineage of isolated strains in every year is shown. Colored bars show information regarding the lineages (lineage 1, red; lineage 2, blue). Download FIG S1, PDF file, 0.1 MB.
Copyright © 2020 Morita et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

The maximum clade credibility tree also showed two distinct lineages that were concurrently distributed in Bengal. The dates of the most recent common ancestor of lineage 1 and lineage 2 were estimated as August 2004 (95% high posterior density [95% HPD], October 2000 to October 2007) and June 2005 (95% HPD, September 2001 to June 2008), respectively (Fig. 1B). Within lineage 1, isolates circulating among the two regions in 2009 formed a different sublineage from another sublineage that persisted in Dhaka. Similarly, lineage 2 diverged into two sublineages, with one sublineage consisting mainly of Kolkata isolates and the other transient sublineage observed until April 2015. It appeared that in both regions, a specific lineage may have adapted to the environmental conditions with continuous modification of the genome and became dominant. In contrast, other sublineages disappeared. Therefore, the effective population size of V. cholerae O1 significantly decreased after 2015 (Fig. 1C).

Genetic characterization of ctxB, rtxA, carR, and VSP-II.Phylogenetic analysis revealed that the Bengali strains could be classified into two lineages, with each lineage possessing different genetic traits (Fig. 1B; Table S1). Each lineage was associated with a ctxB genotype except for four ctxB-negative strains; specifically, isolates in lineage 1 contained ctxB1, and isolates in lineage 2 contained ctxB7. Further, there was a G-to-A mutation at position 13602 in rtxA of lineage 2, which generated a stop codon. Recently polymyxin-susceptible strains were reported among the El Tor biotype owing to an SNV in the carR gene (G265A; resulting in CarR D89N) (20, 21). An isolate in lineage 2 containing mutant carR was first detected in January 2013, and acquisition of its SNV was estimated as occurring in June 2012, consistent with prior estimates (12). These isolates formed a specific cluster and were maintained in the population.

VSP-II was identified to be unique in the seventh pandemic El Tor strains, although the role of the genomic islands (GIs) remains to be established (22). VSP-II constitutes a 26.9-kb genomic region composed of 24 open reading frames (ORFs) between VC0490 and VC0516 according to the annotation of V. cholerae N16961. Previous studies, including those by our laboratory, demonstrated diversity of VSP-II across the strains (18, 23). In particular, we found that all strains partially lacked VSP-II and could be divided into five types: those with a deletion from VC0495 to VC0512 (type 1), those with a deletion from VC0495 to VC0498 (type 2), those with a deletion from VC0495 to VC0498 and a frameshift of VC0490 (type 3), those with a deletion from VC0492 to VC0498 and a frameshift of VC0490 (type 4), and those negative for VSP-II (type 5) (Fig. S2). All strains in lineage 2 possessed type 1 VSP-II. In contrast, lineage 1 contained four types of VSP-II, including type 2 to type 5. The transient sublineage detected in 2009 contained strains carrying type 2 VSP-II and one VSP-II-negative strain (type 5). Subsequently, the major type of VSP-II in lineage 1 gradually shifted from type 3 to type 4 (Table S3). The entire deletion of VSP-II would be caused by excision of the VSP-II locus (type 5), with modification from type 2 to type 4 occurring through stepwise VSP-II deletion.

TABLE S3

Chronological diversity of VSP-II types. Download Table S3, XLSX file, 0.01 MB.
Copyright © 2020 Morita et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S2

Schematic diagram of VSP-II. The transcription direction of each gene is indicated by an arrow, and each type of region is differentially shaded. The VC0490 frameshift in type 2 and 3 is indicated by a broken arrow. Download FIG S2, PDF file, 0.4 MB.
Copyright © 2020 Morita et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

In previous reports, partial sequences of VSP-II were found in the non-O1, non-O139 V. cholerae genome at sites other than the original integration site (23, 24). Among 125 Bengali isolates, only four strains of lineage 2 (BGD101, BGD102, IND036, and IND040) possessed the 18.2-kb GI at the site between VC0153 and VC0154, which shared the 11 ORFs of VSP-II (Fig. S3). The sequence revealed 97% similarity with Vibrio anguillarum VIB43 (CK207_00770 to CK207_00865 of DDBJ/EMBL/GenBank accession number CP023054) (25). This thus represents the first report of the discovery of the novel GI at VC0153 to VC0154 in V. cholerae O1 strains.

FIG S3

Schematic diagram of the novel GI at VC0153 to VC0154 in Bengali V. cholerae O1 and VSP-II in V. cholerae O1 N16961. The transcription direction of each gene is indicated by an arrow, and homologous regions are shaded. Download FIG S3, PDF file, 0.2 MB.
Copyright © 2020 Morita et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Antimicrobial resistance-related genotype analysis.Multiantimicrobial resistance constitutes a major characteristic of recent pathogenic V. cholerae O1 isolates, with ICE of the SXT/R391 family containing determinants of the resistance phenotype in V. cholerae O1 of the seventh cholera pandemic (9). ICE is arranged in a mosaic genetic structure composed of a conserved core region and interspersed variable sequences located in specific sites. The conserved core region comprises 52 genes, of which 25 are related to the function of conjugative transfer. The interspersed variable sequences are located in specific sites termed hot spots (HS1 to -5) and variable regions (vI to vIV). The variable sequences often contain environmental adaptive genes, such as those coding for antimicrobial resistance and restriction and modification systems. As the core region is highly conserved, variation in SXT/R391 ICEs was defined by the variable sequences (26). Accordingly, to investigate the determinant of antimicrobial resistance, we determined the structure of ICEs and detected antimicrobial resistance genes (Fig. S4). ICEs in the strains were also divided into two types, corresponding with the two lineages (Table S1). The ICE in lineage 1 contained antimicrobial resistance genes sul2, dfrA, tetA(D), and strAB. Because ICEs contain several similar transposases, the sequence of the ICE was split into several contigs. The ICE in lineage 1 appeared almost identical to that found in V. cholerae ICDC-2255 isolated in China (ICEVchChn2255) (27). In turn, another ICE in lineage 2 contained antimicrobial resistance genes sul2, dfrA, floR, and strAB. This ICE also revealed almost complete identity to ICEVchInd5 (26). In addition, the ICE of one isolate in lineage 1 lacked the vIII region containing sul2, tetA(D), and strAB. Furthermore, 10 isolates in lineage 2 lacked the ICE region from the vIII region to xis, comprising sul2, floR, and strAB. Based on the phylogenetic tree, these 10 isolates occupied the same branch and transiently appeared. As these antimicrobial resistance genes are flanked by transposase genes, this deletion has often been reported (12, 18, 28).

FIG S4

Structure of SXT/R391 family ICEs and accessory gene organization. SXT/R391 family ICEs are classified by inserted regions, termed hot spots 1 to 5 (HS1 to -5) and variable regions (vI to vIV). Similar sequence regions are indicated by the same color. Locations of antibiotic resistance genes are also represented (Tc, tetracycline resistance; Cm, chloramphenicol resistance; Sm, streptomycin resistance; Su, sulfamethoxazole resistance; Tm, trimethoprim resistance). Download FIG S4, PDF file, 0.1 MB.
Copyright © 2020 Morita et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

The antimicrobial resistance genes in two types of ICE were almost the same; they included sul2, dfrA, and strAB but not floR and tetA(D). Therefore, in addition to their common antimicrobial resistance against streptomycin and SXT, lineage 1 is expected to be resistant to tetracyclines and lineage 2 to chloramphenicol.

Spontaneous mutations in quinolone resistance-determining regions (QRDRs) of the DNA gyrase genes gyrAB and topoisomerase IV genes parCE also serve as important antimicrobial resistance factors in V. cholerae, as fluoroquinolones are also used for cholera treatment (12, 24, 29, 30). We detected mutations in parC that resulted in an S85L substitution and mutations in gyrA that resulted in an S83I amino acid substitution in all strains in both lineages. Furthermore, the strains in lineage 1, except for BGD101, BGD102, IND035, IND036, IND037, IND038, and IND040, contained an additional gyrA mutation that resulted in D660E. However, the mutation GyrA D660E is not reported as being within a QRDR and would not be expected to be associated with quinolone resistance. Consistent with their sequences, these seven strains were located in the same branch of the phylogenetic tree.

DISCUSSION

We performed genome-wide sequencing on 125 Bengali V. cholerae O1 isolates (59 strains from Kolkata, India, and 66 from Dhaka, Bangladesh) obtained from 2009 to 2016 and conducted core genome analysis in conjunction with a global collection of 1,178 V. cholerae isolates. Bengali isolates in this study were related to two clades of global phylogeny, Asian lineage 1 and Asian lineage 2. The relationship between Bengali strains and globally prevalent strains supports the origin of the V. cholerae O1 that spread to other countries in the Bay of Bengal region (9). Lineage 1 and lineage 2 occupied the largest proportion of isolates from Dhaka and Kolkata, respectively. In each region, isolates in another lineage appeared transiently and specific sublineages were maintained. This phenomenon resulted in the decrease of genetic diversity in each region and indicated that each lineage likely adapted to the environmental condition in each region.

Notably, each lineage exhibited different ctxB genotypes. Isolates in lineage 1 harbored ctxB1, and isolates in lineage 2 carried ctxB7. The genotypes of ctxB were related to the clade of the seventh pandemic El Tor: ctxB3 in wave 1, ctxB1 in wave 2 and early wave 3, and ctxB7 in the current wave 3 clade (9). All the isolates in the present study belonged to the wave 3 clade of the seventh pandemic El Tor based on core genome analysis. Therefore, lineage 1 and lineage 2 may be correlated with early wave 3 and current wave 3, respectively. This result indicated that early wave 3 has remained in Bangladesh. In comparison, the isolates in the recent catastrophic outbreaks in Yemen and Haiti were related to lineage 2, and several reports demonstrated that the source of spreading was derived from India (12, 19), whereas lineage 1 has been associated with epidemics in China and Vietnam (27, 31). The factor(s) causing the difference in epidemic scale was unclear. However, different geographical situations may influence the source of the epidemic in various countries.

Moreover, each lineage differed not only in the core genome but also in the genomic islands VSP-II and ICE. The prototypical VSP-II was discovered in 2004 and encoded transcriptional regulators, methyl-accepting chemotaxis proteins, a putative RNase, a putative type IV pilin, a DNA repair protein, an integrase, and a number of hypothetical proteins. Although several variants have been identified from different continents, the role of VSP-II remains unclear (9, 13–17, 23). ICEs constitute genetic elements transferable by conjugation and confer multiantimicrobial resistance. ICEs have been detected since the emergence of wave 2, and several variants have been reported worldwide. As antimicrobial resistance plasmids have rarely been reported in V. cholerae O1 after wave 2, ICEs are therefore currently considered the main factor contributing to antimicrobial resistance in V. cholerae O1 (9, 26).

In the present study, VSP-II variants in each lineage exhibited different trends. In lineage 1, four types of VSP-II variants were identified, from type 2 to type 5 (see Fig. S2 in the supplemental material). The VSP-II variants changed from type 2 to type 4, being deleted stepwise over time. In contrast, the VSP-II variant in lineage 2 was identified as type 1 only. In turn, ICEs confer antimicrobial resistances in bacteria, and all strains, except one Bangladesh isolate, carried ICEs. The ICEs were almost identical to the reported ICEs ICDC-2255 in lineage 1 and ICEVchInd5 in lineage 2. In addition, 1 and 10 ICEs in lineage 1 and lineage 2, respectively, lacked a part of the region containing antimicrobial resistance genes, and these strains rapidly disappeared over time. As antibiotic therapy provides huge selective pressure, these strains might not be compatible with the clinical situation. Furthermore, a portion of the antimicrobial resistance pattern provided by ICEs differed in lineage 1 and lineage 2, which carried the tetracycline resistance gene tetA(D) and the chloramphenicol resistance gene floR, respectively. The difference in VSP-II variants and ICEs might have reflected the fitness of each lineage in the unique environmental conditions in India and Bangladesh, which would result in the existence of two lineages in the Bengal region.

The outbreaks in Haiti and Yemen were triggered by high-risk situations due to the breakdown of infrastructure facilities as a result of earthquake and civil war. It has also been suggested that the lack of preexisting immunity owing to the absence of cholera for 100 years in Haiti might have contributed to instigating the outbreak (2). Therefore, it is anticipated that the lineage 1 clade might also induce outbreaks in any part of the world under similar situations. In such a case, a difference of resistance in each lineage would constitute a serious problem. From the viewpoint of genetic analysis, although almost a full set of resistance genes associated with the new quinolones streptomycin and SXT was common in each lineage, each lineage also carried a different resistance gene associated with tetracycline resistance (lineage 1) or chloramphenicol resistance (lineage 2). Notably, these drugs are also used for cholera treatment, with the tetracycline derivative (doxycycline) especially utilized as a first-line drug (32). However, doxycycline would be less effective for lineage 1. When the infectious agents in lineage 1 spread globally, the use of doxycycline facilitates the replacement of lineage 2 with lineage 1 because doxycycline might fail to prevent lineage 1. Therefore, to provide appropriate treatment, it is important to ascertain whether the infectious agent belongs to lineage 1 or lineage 2.

We consider that surveillance of V. cholerae in Bengal is therefore critical to correctly predict the risk of global cholera spread. We also posit that a better understanding of cholera and the ability to curb this disease can be achieved through genomics. Ultimately, these evaluations will help to build a more complete picture of the global spread and dynamics of this fatal disease.

MATERIALS AND METHODS

Bacterial isolates and whole-genome sequencing.We collected 59 V. cholerae O1 isolates from Dhaka, Bangladesh, and 66 from Kolkata, India (see Table S1 in the supplemental material). The hospitals where isolates originated were icddr,b Dhaka Hospital in Dhaka, Infectious Diseases and Beliaghata General Hospital in Kolkata, and Dr. B C Roy Post Graduate Institute of Pediatric Sciences in Kolkata. A total of 51 strains of Kolkata isolates had already been sequenced in our previous study (17). All isolates were obtained from fecal samples of hospitalized patients with typical cholera symptoms. V. cholerae was isolated by streaking the stool samples on thiosulfate citrate bile salts sucrose (TCBS) agar plates, and typical sucrose-fermenting yellow colonies were considered presumptive V. cholerae. Single isolated yellow colonies were streaked on an LB agar plate (Difco), and then the bacterial lawn on the LB agar plate was subjected to an oxidase and string test as described earlier (31). Oxidase and string test-positive cultures were checked for slide agglutination to confirm their serogroup with polyvalent O1-specific antisera according to the manufacturer’s instruction (Denka Seiken). Genomic DNA was prepared using an DNeasy blood and tissue kit (Qiagen) according to the manufacturer’s instructions. We prepared Illumina libraries using the Nextera XT DNA library preparation kit (Illumina) and sequenced each library on a MiSeq (Illumina) sequencer as 2 × 300 bp paired-end reads. Nucleotide sequence data were submitted to the DDBJ Sequenced Read Archive, and each accession number is given below, as well as in Table S1.

Phylogenetic and phylodynamic reconstruction.To perform phylogenetic analysis, 1,178 genome sequences were obtained from the public database, and M66-2 was used as the outgroup (Table S2). Genome assembly was performed using SPAdes version 3.13.1 with default parameters (33). Variants were called using Snippy version 4.3.6 (https://github.com/tseemann/snippy) using the V. cholerae O1 El Tor N16961 genome (GenBank accession numbers LT907989 and LT907990) as a reference. We excluded the SNVs in recombinogenic regions detected using Gubbins version 2.3.4 (34), along with the SNVs in the repeat and prophage regions of the N16961 genome, which were identified using NUCmer (35) and PHAST (36) for core genome phylogeny. A maximum likelihood phylogenetic tree was generated using RAxML version 8.2.0 (37) with 1,000 bootstrap iterations.

To estimate the phylodynamics of the V. cholerae O1 isolates in the Bengal region, we performed a temporal analysis using the Bayesian Evolutionary Analysis Sampling Trees (BEAST) version 2.4.7 software package (38). A relaxed clock exponential model and an HKY nucleotide substitution model were implemented using the Markov chain Monte Carlo method run for 100 million generations and sampled every 1,000 generations. The effective sample sizes were >200 for all estimated parameters. The tree data were summarized to generate the maximum clade credibility tree using TreeAnnotator with first 10% burn-in. The effective population size was reconstructed using the Bayesian coalescent skyline plot implemented in Tracer version 1.6.0. These results were visualized using Interactive Tree Of Life (iTOL) version 4 (https://itol.embl.de) (39).

Identification of VSP-II and novel genomic islands.The contigs of the draft genome from each isolate were aligned against the VSP-II region (VC0489 to VC0517 of N16961) using BLAST+ version 2.6.0 to identify the deletion of VSP-II (40). The sequence from VC0153 to VC0154 was extracted from the draft genome sequence of each strain using BLAST+ version 2.6.0 and an in-house Perl script to elucidate whether the genetic element was inserted at this locus.

Identification of ICE.The contigs containing the conserved core region of ICE were selected using BLAST+ version 2.6.0, and sequence comparisons were performed with MAUVE (41). Sequences of ICEVchInd5 and ICE in ICEVchChn2255 (GenBank accession numbers GQ463142 and KT151660) were used as references. One strain (BGD138) was found to lack the entire ICE sequence, as no genetic element was located at the ICE insertion sites VC0658 and VC0659.

Data availability.Nucleotide sequence data generated in this study are available in the DDBJ/EMBL/GenBank databases under accession numbers DRX179739 to DRX179812.

ACKNOWLEDGMENTS

We thank Kanako Oba and Yu Takizawa for their technical assistance.

This research was supported by AMED under grant numbers JP19fk0108049 and JP20fk0108139.

We thank Editage for English language editing. icddr,b authors are grateful to the hospital and laboratory staff for their valuable support and the Governments of Bangladesh, Canada, Sweden, and the United Kingdom for providing core/unrestricted support.

FOOTNOTES

    • Received 20 August 2020
    • Accepted 24 August 2020
    • Published 10 November 2020
  • Copyright © 2020 Morita et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

REFERENCES

  1. 1.↵
    1. Harris JB,
    2. LaRocque RC,
    3. Qadri F,
    4. Ryan ET,
    5. Calderwood SB
    . 2012. Cholera. Lancet 379:2466–2476. doi:10.1016/S0140-6736(12)60436-X.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    CDC. 2010. Cholera outbreak—Haiti, October 2010. MMWR Morb Mortal Wkly Rep 59:1411.
    OpenUrlPubMed
  3. 3.↵
    1. Balakrishnan VS
    . 2017. Cholera in Yemen. Lancet Infect Dis 17:700–701. doi:10.1016/S1473-3099(17)30352-3.
    OpenUrlCrossRef
  4. 4.↵
    1. Guillaume Y,
    2. Ternier R,
    3. Vissieres K,
    4. Casseus A,
    5. Chery MJ,
    6. Ivers LC
    . 2018. Responding to cholera in Haiti: implications for the national plan to eliminate cholera by 2022. J Infect Dis 218:S167–S170. doi:10.1093/infdis/jiy491.
    OpenUrlCrossRef
  5. 5.↵
    1. Camacho A,
    2. Bouhenia M,
    3. Alyusfi R,
    4. Alkohlani A,
    5. Naji MAM,
    6. de Radiguès X,
    7. Abubakar AM,
    8. Almoalmi A,
    9. Seguin C,
    10. Sagrado MJ,
    11. Poncin M,
    12. McRae M,
    13. Musoke M,
    14. Rakesh A,
    15. Porten K,
    16. Haskew C,
    17. Atkins KE,
    18. Eggo RM,
    19. Azman AS,
    20. Broekhuijsen M,
    21. Saatcioglu MA,
    22. Pezzoli L,
    23. Quilici ML,
    24. Al-Mesbahy AR,
    25. Zagaria N,
    26. Luquero FJ
    . 2018. Cholera epidemic in Yemen, 2016–18: an analysis of surveillance data. Lancet Glob Health 6:e680–e690. doi:10.1016/S2214-109X(18)30230-4.
    OpenUrlCrossRef
  6. 6.↵
    1. Safa A,
    2. Nair GB,
    3. Kong RY
    . 2010. Evolution of new variants of Vibrio cholerae O1. Trends Microbiol 18:46–54. doi:10.1016/j.tim.2009.10.003.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Bhattacharya MK,
    2. Bhattacharya SK,
    3. Garg S,
    4. Saha PK,
    5. Dutta D,
    6. Nair GB,
    7. Deb BC,
    8. Das KP
    . 1993. Outbreak of Vibrio cholerae non-O1 in India and Bangladesh. Lancet 341:1346–1347. doi:10.1016/0140-6736(93)90855-B.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Kim EJ,
    2. Lee CH,
    3. Nair GB,
    4. Kim DW
    . 2015. Whole-genome sequence comparisons reveal the evolution of Vibrio cholerae O1. Trends Microbiol 23:479–489. doi:10.1016/j.tim.2015.03.010.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Mutreja A,
    2. Kim DW,
    3. Thomson NR,
    4. Connor TR,
    5. Lee JH,
    6. Kariuki S,
    7. Croucher NJ,
    8. Choi SY,
    9. Harris SR,
    10. Lebens M,
    11. Niyogi SK,
    12. Kim EJ,
    13. Ramamurthy T,
    14. Chun J,
    15. Wood JL,
    16. Clemens JD,
    17. Czerkinsky C,
    18. Nair GB,
    19. Holmgren J,
    20. Parkhill J,
    21. Dougan G
    . 2011. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 477:462–465. doi:10.1038/nature10392.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Ghosh P,
    2. Naha A,
    3. Basak S,
    4. Ghosh S,
    5. Ramamurthy T,
    6. Koley H,
    7. Nandy RK,
    8. Shinoda S,
    9. Watanabe H,
    10. Mukhopadhyay AK
    . 2014. Haitian variant tcpA in Vibrio cholerae O1 El Tor strains in Kolkata, India. J Clin Microbiol 52:1020–1021. doi:10.1128/JCM.03042-13.
    OpenUrlFREE Full Text
  11. 11.↵
    1. Dolores J,
    2. Satchell KJF
    . 2013. Analysis of Vibrio cholerae genome sequences reveals unique rtxA variants in environmental strains and an rtxA-null mutation in recent altered El Tor isolates. mBio 4:e00624-12. doi:10.1128/mBio.00624-12.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Weill FX,
    2. Domman D,
    3. Njamkepo E,
    4. Almesbahi AA,
    5. Naji M,
    6. Nasher SS,
    7. Rakesh A,
    8. Assiri AM,
    9. Sharma NC,
    10. Kariuki S,
    11. Pourshafie MR,
    12. Rauzier J,
    13. Abubakar A,
    14. Carter JY,
    15. Wamala JF,
    16. Seguin C,
    17. Bouchier C,
    18. Malliavin T,
    19. Bakhshi B,
    20. Abulmaali HHN,
    21. Kumar D,
    22. Njoroge SM,
    23. Malik MR,
    24. Kiiru J,
    25. Luquero FJ,
    26. Azman AS,
    27. Ramamurthy T,
    28. Thomson NR,
    29. Quilici ML
    . 2019. Genomic insights into the 2016–2017 cholera epidemic in Yemen. Nature 565:230–233. doi:10.1038/s41586-018-0818-3.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Nusrin S,
    2. Gil AI,
    3. Bhuiyan NA,
    4. Safa A,
    5. Asakura M,
    6. Lanata CF,
    7. Hall E,
    8. Miranda H,
    9. Huapaya B,
    10. Vargas G C,
    11. Luna MA,
    12. Sack DA,
    13. Yamasaki S,
    14. Nair GB
    . 2009. Peruvian Vibrio cholerae O1 El Tor strains possess a distinct region in the Vibrio seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains. J Med Microbiol 58:342–354. doi:10.1099/jmm.0.005397-0.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Taviani E,
    2. Grim CJ,
    3. Choi J,
    4. Chun J,
    5. Haley B,
    6. Hasan NA,
    7. Huq A,
    8. Colwell RR
    . 2010. Discovery of novel Vibrio cholerae VSP-II genomic islands using comparative genomic analysis. FEMS Microbiol Lett 308:130–137. doi:10.1111/j.1574-6968.2010.02008.x.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Bhuiyan NA,
    2. Nusrin S,
    3. Ansaruzzaman M,
    4. Islam A,
    5. Sultana M,
    6. Alam M,
    7. Islam MA,
    8. Cravioto A,
    9. Mukhopadhyay AK,
    10. Nair GB,
    11. Mwasna JC,
    12. Endtz HP
    . 2012. Genetic characterization of Vibrio cholerae O1 strains isolated in Zambia during 1996–2004 possessing the unique VSP-II region of El Tor variant. Epidemiol Infect 140:510–518. doi:10.1017/S0950268811000926.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Abd El Ghany M,
    2. Chander J,
    3. Mutreja A,
    4. Rashid M,
    5. Hill-Cawthorne GA,
    6. Ali S,
    7. Naeem R,
    8. Thomson NR,
    9. Dougan G,
    10. Pain A
    . 2014. The population structure of Vibrio cholerae from the Chandigarh Region of Northern India. PLoS Negl Trop Dis 8:e2981. doi:10.1371/journal.pntd.0002981.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Imamura D,
    2. Morita M,
    3. Sekizuka T,
    4. Mizuno T,
    5. Takemura T,
    6. Yamashiro T,
    7. Chowdhury G,
    8. Pazhani GP,
    9. Mukhopadhyay AK,
    10. Ramamurthy T,
    11. Miyoshi SI,
    12. Kuroda M,
    13. Shinoda S,
    14. Ohnishi M
    . 2017. Comparative genome analysis of VSP-II and SNPs reveals heterogenic variation in contemporary strains of Vibrio cholerae O1 isolated from cholera patients in Kolkata, India. PLoS Negl Trop Dis 11:e0005386. doi:10.1371/journal.pntd.0005386.
    OpenUrlCrossRef
  18. 18.↵
    1. Weill FX,
    2. Domman D,
    3. Njamkepo E,
    4. Tarr C,
    5. Rauzier J,
    6. Fawal N,
    7. Keddy KH,
    8. Salje H,
    9. Moore S,
    10. Mukhopadhyay AK,
    11. Bercion R,
    12. Luquero FJ,
    13. Ngandjio A,
    14. Dosso M,
    15. Monakhova E,
    16. Garin B,
    17. Bouchier C,
    18. Pazzani C,
    19. Mutreja A,
    20. Grunow R,
    21. Sidikou F,
    22. Bonte L,
    23. Breurec S,
    24. Damian M,
    25. Njanpop-Lafourcade BM,
    26. Sapriel G,
    27. Page AL,
    28. Hamze M,
    29. Henkens M,
    30. Chowdhury G,
    31. Mengel M,
    32. Koeck JL,
    33. Fournier JM,
    34. Dougan G,
    35. Grimont PAD,
    36. Parkhill J,
    37. Holt KE,
    38. Piarroux R,
    39. Ramamurthy T,
    40. Quilici ML,
    41. Thomson NR
    . 2017. Genomic history of the seventh pandemic of cholera in Africa. Science 358:785–789. doi:10.1126/science.aad5901.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Domman D,
    2. Quilici ML,
    3. Dorman MJ,
    4. Njamkepo E,
    5. Mutreja A,
    6. Mather AE,
    7. Delgado G,
    8. Morales-Espinosa R,
    9. Grimont PAD,
    10. Lizárraga-Partida ML,
    11. Bouchier C,
    12. Aanensen DM,
    13. Kuri-Morales P,
    14. Tarr CL,
    15. Dougan G,
    16. Parkhill J,
    17. Campos J,
    18. Cravioto A,
    19. Weill FX,
    20. Thomson NR
    . 2017. Integrated view of Vibrio cholerae in the Americas. Science 358:789–793. doi:10.1126/science.aao2136.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Samanta P,
    2. Ghosh P,
    3. Chowdhury G,
    4. Ramamurthy T,
    5. Mukhopadhyay AK
    . 2015. Sensitivity to polymyxin B in El Tor Vibrio cholerae O1 strain, Kolkata, India. Emerg Infect Dis 21:2100–2102. doi:10.3201/eid2111.150762.
    OpenUrlCrossRef
  21. 21.↵
    1. Samanta P,
    2. Mandal RS,
    3. Saha RN,
    4. Shaw S,
    5. Ghosh P,
    6. Dutta S,
    7. Ghosh A,
    8. Imamura D,
    9. Morita M,
    10. Ohnishi M,
    11. Ramamurthy T,
    12. Mukhopadhyay AK
    . 2020. A point mutation in carR is involved in the emergence of polymyxin B-sensitive Vibrio cholerae O1 El Tor biotype by influencing gene transcription. Infect Immun 88:e00080-20. doi:10.1128/IAI.00080-20.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Dziejman M,
    2. Balon E,
    3. Boyd D,
    4. Fraser CM,
    5. Heidelberg JF,
    6. Mekalanos JJ
    . 2002. Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc Natl Acad Sci U S A 99:1556–1561. doi:10.1073/pnas.042667999.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Nguyen TH,
    2. Pham TD,
    3. Higa N,
    4. Iwashita H,
    5. Takemura T,
    6. Ohnishi M,
    7. Morita K,
    8. Yamashiro T
    . 2018. Analysis of Vibrio seventh pandemic island II and novel genomic islands in relation to attachment sequences among a wide variety of Vibrio cholerae strains. Microbiol Immunol 62:150–157. doi:10.1111/1348-0421.12570.
    OpenUrlCrossRef
  24. 24.↵
    1. Hasan NA,
    2. Choi SY,
    3. Eppinger M,
    4. Clark PW,
    5. Chen A,
    6. Alam M,
    7. Haley BJ,
    8. Taviani E,
    9. Hine E,
    10. Su Q,
    11. Tallon LJ,
    12. Prosper JB,
    13. Furth K,
    14. Hoq MM,
    15. Li H,
    16. Fraser-Liggett CM,
    17. Cravioto A,
    18. Huq A,
    19. Ravel J,
    20. Cebula TA,
    21. Colwell RR
    . 2012. Genomic diversity of 2010 Haitian cholera outbreak strains. Proc Natl Acad Sci U S A 109:E2010–E2017. doi:10.1073/pnas.1207359109.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Holm KO,
    2. Bækkedal C,
    3. Söderberg JJ,
    4. Haugen P
    . 2018. Complete genome sequences of seven Vibrio anguillarum strains as derived from PacBio sequencing. Genome Biol Evol 10:1127–1131. doi:10.1093/gbe/evy074.
    OpenUrlCrossRef
  26. 26.↵
    1. Wozniak RA,
    2. Fouts DE,
    3. Spagnoletti M,
    4. Colombo MM,
    5. Ceccarelli D,
    6. Garriss G,
    7. Déry C,
    8. Burrus V,
    9. Waldor MK
    . 2009. Comparative ICE genomics: insights into the evolution of the SXT/R391 family of ICEs. PLoS Genet 5:e1000786. doi:10.1371/journal.pgen.1000786.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Wang R,
    2. Yu D,
    3. Yue J,
    4. Kan B
    . 2016. Variations in SXT elements in epidemic Vibrio cholerae O1 El Tor strains in China. Sci Rep 6:22733. doi:10.1038/srep22733.
    OpenUrlCrossRef
  28. 28.↵
    1. Katz LS,
    2. Petkau A,
    3. Beaulaurier J,
    4. Tyler S,
    5. Antonova ES,
    6. Turnsek MA,
    7. Guo Y,
    8. Wang S,
    9. Paxinos EE,
    10. Orata F,
    11. Gladney LM,
    12. Stroika S,
    13. Folster JP,
    14. Rowe L,
    15. Freeman MM,
    16. Knox N,
    17. Frace M,
    18. Boncy J,
    19. Graham M,
    20. Hammer BK,
    21. Boucher Y,
    22. Bashir A,
    23. Hanage WP,
    24. Van Domselaar G,
    25. Tarr CL
    . 2013. Evolutionary dynamics of Vibrio cholerae O1 following a single-source introduction to Haiti. mBio 4:e00398-13. doi:10.1128/mBio.00398-13.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Ismail H,
    2. Smith AM,
    3. Tau NP,
    4. Sooka A,
    5. Keddy KH
    , Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). 2013. Cholera outbreak in South Africa, 2008–2009: laboratory analysis of Vibrio cholerae O1 strains. J Infect Dis 208:S39–S45. doi:10.1093/infdis/jit200.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Dixit SM,
    2. Johura FT,
    3. Manandhar S,
    4. Sadique A,
    5. Rajbhandari RM,
    6. Mannan SB,
    7. Rashid MU,
    8. Islam S,
    9. Karmacharya D,
    10. Watanabe H,
    11. Sack RB,
    12. Cravioto A,
    13. Alam M
    . 2014. Cholera outbreaks (2012) in three districts of Nepal reveal clonal transmission of multi-drug resistant Vibrio cholerae O1. BMC Infect Dis 14:392. doi:10.1186/1471-2334-14-392.
    OpenUrlCrossRef
  31. 31.↵
    1. Pang B,
    2. Du P,
    3. Zhou Z,
    4. Diao B,
    5. Cui Z,
    6. Zhou H,
    7. Kan B
    . 2016. The transmission and antibiotic resistance variation in a multiple drug resistance clade of Vibrio cholerae circulating in multiple countries in Asia. PLoS One 11:e0149742. doi:10.1371/journal.pone.0149742.
    OpenUrlCrossRef
  32. 32.↵
    Global Task Force on Cholera Control. 2004. Cholera outbreak: assessing the outbreak response and improving preparedness. World Health Organization, Geneva, Switzerland. https://www.who.int/cholera/publications/final%20outbreak%20booklet%20260105-OMS.pdf.
  33. 33.↵
    1. Bankevich A,
    2. Nurk S,
    3. Antipov D,
    4. Gurevich AA,
    5. Dvorkin M,
    6. Kulikov AS,
    7. Lesin VM,
    8. Nikolenko SI,
    9. Pham S,
    10. Prjibelski AD,
    11. Pyshkin AV,
    12. Sirotkin AV,
    13. Vyahhi N,
    14. Tesler G,
    15. Alekseyev MA,
    16. Pevzner PA
    . 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi:10.1089/cmb.2012.0021.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Croucher NJ,
    2. Page AJ,
    3. Connor TR,
    4. Delaney AJ,
    5. Keane JA,
    6. Bentley SD,
    7. Parkhill J,
    8. Harris SR
    . 2015. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 43:e15. doi:10.1093/nar/gku1196.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Delcher AL1,
    2. Phillippy A,
    3. Carlton J,
    4. Salzberg SL
    . 2002. Fast algorithms for large-scale genome alignment and comparison. Nucleic Acids Res 30:2478–2483. doi:10.1093/nar/30.11.2478.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Zhou Y,
    2. Liang Y,
    3. Lynch KH,
    4. Dennis JJ,
    5. Wishart DS
    . 2011. PHAST: a fast phage search tool. Nucleic Acids Res 39:W347–W352. doi:10.1093/nar/gkr485.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Stamatakis A
    . 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22:2688–2690. doi:10.1093/bioinformatics/btl446.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Bouckaert R,
    2. Heled J,
    3. Kühnert D,
    4. Vaughan T,
    5. Wu CH,
    6. Xie D,
    7. Suchard MA,
    8. Rambaut A,
    9. Drummond AJ
    . 2014. BEAST 2: a software platform for Bayesian evolutionary analysis. PLoS Comput Biol 10:e1003537. doi:10.1371/journal.pcbi.1003537.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Letunic I,
    2. Bork P
    . 2019. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res 47:W256–W259. doi:10.1093/nar/gkz239.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Camacho C,
    2. Coulouris G,
    3. Avagyan V,
    4. Ma N,
    5. Papadopoulos J,
    6. Bealer K,
    7. Madden TL
    . 2009. BLAST+: architecture and applications. BMC Bioinformatics 10:421. doi:10.1186/1471-2105-10-421.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Darling AC,
    2. Mau B,
    3. Blattner FR,
    4. Perna NT
    . 2004. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 14:1394–1403. doi:10.1101/gr.2289704.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Whole-Genome Analysis of Clinical Vibrio cholerae O1 in Kolkata, India, and Dhaka, Bangladesh, Reveals Two Lineages of Circulating Strains, Indicating Variation in Genomic Attributes
Daichi Morita, Masatomo Morita, Munirul Alam, Asish K. Mukhopadhyay, Fatema-tuz Johura, Marzia Sultana, Shirajum Monira, Niyaz Ahmed, Goutam Chowdhury, Shanta Dutta, Thandavarayan Ramamurthy, Prosenjit Samanta, Eizo Takahashi, Keinosuke Okamoto, Hidemasa Izumiya, Makoto Ohnishi
mBio Nov 2020, 11 (6) e01227-20; DOI: 10.1128/mBio.01227-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Whole-Genome Analysis of Clinical Vibrio cholerae O1 in Kolkata, India, and Dhaka, Bangladesh, Reveals Two Lineages of Circulating Strains, Indicating Variation in Genomic Attributes
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Whole-Genome Analysis of Clinical Vibrio cholerae O1 in Kolkata, India, and Dhaka, Bangladesh, Reveals Two Lineages of Circulating Strains, Indicating Variation in Genomic Attributes
Daichi Morita, Masatomo Morita, Munirul Alam, Asish K. Mukhopadhyay, Fatema-tuz Johura, Marzia Sultana, Shirajum Monira, Niyaz Ahmed, Goutam Chowdhury, Shanta Dutta, Thandavarayan Ramamurthy, Prosenjit Samanta, Eizo Takahashi, Keinosuke Okamoto, Hidemasa Izumiya, Makoto Ohnishi
mBio Nov 2020, 11 (6) e01227-20; DOI: 10.1128/mBio.01227-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

genomics
lineage
phylogenetic analysis
whole-genome sequencing

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511